News & Events

Follow us here for the latest updates on our platform technology development, assets and corporate events.

PRESS RELEASES

Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer.

Cell BioEngines Licenses Patent for Allogeneic Hematopoietic Cell Transplantation in Oncology.

Cell BioEngines Founder and CEO Dr. Ajay Vishwakarma Interview at IndieBio NY Class 6 Online Demo Day.